Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

Share Price is delayed by 15 minutes
Get Live Data
49.00    0.00 (0.00%)
Bid:
48.00
Ask:
50.00
Spread: 2.00 (4.167%)
Market Cap: £35.50m
PCIP Live PriceLast checked at - London Stock Exchange

Intraday Pci-pal Share Chart

HIPAA, HITRUST & SOC 2 Type II certification

14 Apr 2026 07:00

RNS Number : 2462A
PCI-PAL PLC
14 April 2026
 

 

 

Reach - Non-Regulatory Announcement

 

14 April 2026

 

PCI-PAL PLC

("PCI Pal", "the Group", or the "Company")

 

Achievement of HIPAA, HITRUST, and SOC 2 Type II certification

 

PCI-PAL PLC (AIM: PCIP), the global cloud provider of secure payment solutions for business communications, is pleased to announce that it has successfully achieved HIPAA, HITRUST and SOC 2 Type II compliance, enhancing its ability to support enterprise customers operating in highly regulated environments, particularly in the United States.

 

HIPAA (Health Insurance Portability and Accountability Act) is the key US healthcare data protection regulation, imposing strict security and privacy requirements on organisations handling sensitive patient information across the healthcare industry.

 

HITRUST is a leading certifiable security framework in the US healthcare sector, providing a comprehensive and auditable approach to managing data protection, privacy and regulatory compliance, and is often used to demonstrate alignment with HIPAA requirements.

 

SOC 2 Type II is a widely recognised and adopted independent audit standard in the US, validating that strong security and data protection controls are operating effectively over time, and is commonly expected by enterprise customers in the US.

 

Combined these achievements are exceptional in the Company's industry and reflect PCI Pal's continued commitment to maintaining the highest levels of data security, privacy, and regulatory compliance for not only its customers, but also in supporting its partners many of whom operate extensively across the US enterprise space.

 

Commenting, James Barham, Chief Executive Officer of PCI Pal, said:

 

"Achieving HIPAA and HITRUST audited compliance, alongside our successful SOC 2 Type II attestation, is an important milestone for PCI Pal. It underscores our continued investment in robust and regulated security frameworks, which is supporting enhanced competitive differentiation and positioning for the Company, as well as building additional customer trust. Together, they provide our customers with independently validated assurance in our ability to meet rigorous compliance requirements while delivering secure, reliable, enterprise-grade cloud solutions.

 

"For our partners, these achievements further strengthen an already comprehensive compliance and security foundation across the PCI Pal cloud platform. They also reinforce the basis for mutual growth across both human and AI engagement environments, as we continue to deliver incremental value and deepen strategic relationships.

 

"With expansion across enterprise customers in the US a key strategic goal, these standards further enhance our ability to engage with large, regulated organisations and position PCI Pal to capitalise on its significant market opportunity at pace."

 

 

For further information, please contact:

 

PCI-PAL PLC

Via Walbrook PR

James Barham - Chief Executive Officer

Ryan Murray - Chief Financial Officer

 

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

+44 (0) 20 7227 0500

Marc Milmo/ Fergus Sullivan (Corporate Finance)

Sunila De Silva (Corporate Broking)

 

Walbrook PR

+44 (0) 20 7933 8780

Tom Cooper/Nick Rome

+44 (0) 797 122 1972

tom.cooper@walbrookpr.com

 

 

About PCI Pal:

 

PCI Pal is a leading provider of secure, cloud-based payment and data protection solutions that enable organisations to take frictionless, compliant payments seamlessly integrated to any business communications environment including voice, chat, messaging, social media, and email. PCI Pal's platform supports all forms of customer engagement, whether human-to-human or AI-driven conversations.

 

PCI Pal has an extensive partner eco-system with its products resold by many of the world's leading Communications, CCaaS, and UCaaS vendors. Its platform integrates with a broad range of digital payment methods and connects to the majority of leading payment service providers globally.

 

For more information visit www.pcipal.com or follow the team on LinkedIn: https://www.linkedin.com/company/pci-pal/

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAXXLFFQZLBBBF
Date   Source Headline
16th Aug 20227:00 amRNSNotice of Results Analyst Briefing & Investor Pres
27th Jul 20227:00 amRNSTrading Update & Notice of Results
1st Jul 20227:00 amRNSDirectorate Change
30th Jun 20221:56 pmRNSIssue of Equity
28th Jun 20227:00 amRNSUpdate on Patent Infringement Claims
26th Apr 20227:00 amRNSTrading Update
7th Apr 20227:00 amRNSPDMR share purchase
24th Mar 20227:00 amRNSDirectorate Change
22nd Mar 20227:00 amRNSNew U.S. Patent Approved Covering Cloud IP
15th Mar 20227:00 amRNSStrategic Partnership Driving Open Banking Opps
9th Mar 202211:12 amRNSPDMR/PCA Shareholding
4th Mar 20227:00 amRNSIssue of Options
3rd Mar 20223:50 pmRNSDirector/PDMR Share Purchase
2nd Mar 20224:52 pmRNSPCA/PDMR Shareholding
2nd Mar 202212:05 pmRNSDirector/PDMR Share Purchase
2nd Mar 20228:05 amRNSDirector/PDMR Share Purchases
1st Mar 20227:00 amRNSInterim Results, Analyst Briefing & Investor Pres
19th Jan 20224:41 pmRNSSecond Price Monitoring Extn
19th Jan 20224:35 pmRNSPrice Monitoring Extension
19th Jan 20227:00 amRNSTrading Update, Notice of Results & Investor Pres
5th Jan 20227:00 amRNSHolding(s) in Company
10th Dec 20217:00 amRNSIssue of Equity & Total Voting Rights
10th Nov 20214:05 pmRNSResult of AGM
10th Nov 20217:01 amRNSAGM Trading Update
10th Nov 20217:00 amRNSPatent Case Update
18th Oct 20214:15 pmRNSHolding(s) in Company
14th Oct 20217:00 amRNSAnnual Financial Report & Notice of AGM
12th Oct 20217:00 amRNSAmazon Connect and AWS Marketplace availability
16th Sep 20217:00 amRNSUnfounded allegations of patent infringement
18th Aug 20217:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
16th Aug 20217:00 amRNSAppointment of Advisory Committee Members
23rd Jul 20217:30 amRNSHolding(s) in Company
21st Jul 20217:00 amRNSTrading Update
21st Jun 20217:00 amRNSDirector Share Purchase
15th Jun 202110:00 amRNSHolding(s) in Company
8th Jun 20217:00 amRNSTrading Update & Repayment of Debt Facility
25th May 20214:42 pmRNSDirector/PDMR Shareholding
14th May 20215:50 pmRNSHolding(s) in Company
11th May 20217:00 amRNSHolding(s) in Company
10th May 20215:38 pmRNSHolding(s) in Company
10th May 20214:22 pmRNSHolding(s) in Company
10th May 20214:18 pmRNSHolding(s) in Company
10th May 202110:52 amRNSHolding(s) in Company
10th May 20217:00 amRNSIssue of Equity
30th Apr 202112:09 pmRNSResult of Fundraising & Total Voting Rights
30th Apr 20217:00 amRNSProposed Placing to raise £5.5m
20th Apr 20215:38 pmRNSHolding(s) in Company
13th Apr 202110:14 amRNSGrant of Share Options
1st Apr 202111:18 amRNSIssue of Equity
10th Mar 20213:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.